Urology · Plymouth, IN
NPI
1235270067
Since 2007
Specialty
Urology
Code 208800000X
Group practices
6
Medicare group memberships
Hospitals
6
Hospital affiliations
1919 Lake Ave Ste 104
Plymouth, IN, 46563
Phone (574) 948-5390
Groups this clinician bills Medicare through
Medicare paid, 2024
$263K
7,629 services
Medicare patients, 2024
891
Average age 75
Drug cost, 2024
$2.1M
4,506 prescriptions
Company payments, 2025
$1,324
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adam E Perlmutter was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 509 times for 384 patients. In total Adam E Perlmutter billed 7,629 services in 74 codes, and Medicare paid $263K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 509 | 384 | $11.52 | $5,863 |
| 99213 Office E&M - Established | Office | 454 | 382 | $59.86 | $27K |
| 99214 Office E&M - Established | Office | 377 | 272 | $84.52 | $32K |
| 51798 Ultrasound - Nonspecific | Office | 246 | 221 | $6.98 | $1,717 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 138 | 17 | $141.57 | $20K |
| 99203 Office E&M - New | Office | 123 | 123 | $70.40 | $8,659 |
| 81003 Clinical Chemistry | Office | 114 | 96 | $2.16 | $246 |
| 52000 Cystourethroscopy | Office | 100 | 81 | $151.36 | $15K |
| 99231 Hospital E&M - Subsequent | Facility | 81 | 65 | $34.87 | $2,825 |
| 99232 Hospital E&M - Subsequent | Facility | 80 | 58 | $56.01 | $4,481 |
| 99204 Office E&M - New | Office | 70 | 70 | $108.39 | $7,587 |
| 51741 Test - Miscellaneous | Office | 59 | 57 | $7.79 | $460 |
| 99222 Hospital E&M - Initial | Facility | 52 | 51 | $95.85 | $4,984 |
| 74420 Standard X-ray | Facility | 50 | 39 | $18.09 | $904 |
| 55700 Other Organ Systems | Facility | 41 | 41 | $87.47 | $3,586 |
By year: 2022 $266K for 8,156 services; 2023 $272K for 8,890 services; 2024 $263K for 7,629 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 114 | 96 | $2.16 | $246 |
| 81001 Clinical Chemistry | 14 | 14 | $2.53 | $35.36 |
Medicare prescription drug claims, 2024
In 2024, the drug Adam E Perlmutter prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,242 prescriptions and refills. In total Adam E Perlmutter wrote 4,506 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,242 | 3,489 | 399 | $16K |
| Finasteride Generic | 481 | 1,326 | 159 | $5,503 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 388 | 887 | 140 | $11K |
| Solifenacin Succinate Generic | 327 | 850 | 123 | $27K |
| Cephalexin Generic | 314 | 409 | 208 | $1,851 |
| Myrbetriq Mirabegron | 264 | 511 | 72 | $229K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 215 | 608 | 71 | $4,325 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 162 | 162 | 138 | $529 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 133 | 139 | 116 | $361 |
| Imipramine Hcl Generic | 117 | 305 | 48 | $2,941 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 108 | 127 | 62 | $1,886 |
| Ciprofloxacin Hcl Generic | 60 | 60 | 50 | $264 |
| Orgovyx Relugolix | 60 | 60 | Under 11 | $200K |
| Xtandi Enzalutamide | 56 | 56 | Under 11 | $790K |
| Levofloxacin Generic | 48 | 48 | 43 | $124 |
Brand drugs: - claims; generic drugs: 3,978 claims; opioid claims: 170.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adam E Perlmutter $1,324 ($1,324 in general payments such as food, travel and fees) from 19 companies. The largest payer was Sumitomo Pharma America, Inc. with $200.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 10 | $200 |
| Urogen Pharma, Inc. URGN | 11 | $199 |
| Intuitive Surgical, Inc. ISRG | 2 | $153 |
| Novo Nordisk Inc NVO | 1 | $125 |
| Janssen Biotech, Inc. JNJ | 4 | $119 |
| Verity Pharmaceuticals Inc. | 5 | $93.51 |
| Abbvie Inc. ABBV | 2 | $67.25 |
| Astellas Pharma US Inc 4503.T | 3 | $66.56 |
| Laborie Medical Technologies Corp. | 2 | $45.09 |
| Olympus America Inc. | 1 | $41.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.